Development of Indicators to Assess Quality of Care for Prostate Cancer

Nupur Nag, Jeremy Millar, Ian D. Davis, Shaun Costello, James B. Duthie, Stephen Mark, Warick Delprado, David Smith, David Pryor, David Galvin, Frank Sullivan, Áine C. Murphy, David Roder, Hany Elsaleh, David Currow, Craig White, Marketa Skala, Kim L. Moretti, Tony Walker, Paolo De IesoAndrew Brooks, Peter Heathcote, Mark Frydenberg, Jeffery Thavaseelan, Sue M. Evans

Research output: Contribution to journalArticlepeer-review

17 Citations (Scopus)


Background: The development, monitoring, and reporting of indicator measures that describe standard of care provide the gold standard for assessing quality of care and patient outcomes. Although indicator measures have been reported, little evidence of their use in measuring and benchmarking performance is available. A standard set, defining numerator, denominator, and risk adjustments, will enable global benchmarking of quality of care. Objective: To develop a set of indicators to enable assessment and reporting of quality of care for men with localised prostate cancer (PCa). Design, setting, and participants: Candidate indicators were identified from the literature. An international panel was invited to participate in a modified Delphi process. Teleconferences were held before and after each voting round to provide instruction and to review results. Outcome measurements and statistical analysis: Panellists were asked to rate each proposed indicator on a Likert scale of 1–9 in a two-round iterative process. Calculations required to report on the endorsed indicators were evaluated and modified to reflect the data capture of the Prostate Cancer Outcomes Registry–Australia and New Zealand (PCOR-ANZ). Results and limitations: A total of 97 candidate indicators were identified, of which 12 were endorsed. The set includes indicators covering pre-, intra-, and post-treatment of PCa care, within the limits of the data captured by PCOR-ANZ. Conclusions: The 12 endorsed quality measures enable international benchmarking on the quality of care of men with localised PCa. Reporting on these indicators enhances safety and efficacy of treatment, reduces variation in care, and can improve patient outcomes. Patient summary: PCa has the highest incidence of all cancers in men. Early diagnosis and relatively high survival rates mean issues of quality of care and best possible health outcomes for patients are important. This paper identifies 12 important measurable quality indicators in PCa care. This paper identifies 12 important measurable quality indicators in prostate cancer care. These measures provide a global standard for registries to benchmark quality of care of men with localised prostate cancer.

Original languageEnglish
Pages (from-to)57-63
Number of pages7
JournalEuropean Urology Focus
Issue number1
Publication statusPublished - Jan 2018


  • Clinical registries
  • Population health
  • Prostate cancer
  • Quality indicators
  • Quality measures


Dive into the research topics of 'Development of Indicators to Assess Quality of Care for Prostate Cancer'. Together they form a unique fingerprint.

Cite this